You have 9 free searches left this month | for more free features.

newly diagnosed multiple myeloma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Guiding the Treatment in Older Newly Diagnosed Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Frailty
    • (no location specified)
    Oct 30, 2023

    Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,

    Not yet recruiting
    • Multiple Myeloma
    • Renal Failure
    • Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
    • Augusta, Georgia
      Georgia Cancer Center-Augusta University
    Nov 16, 2023

    Stem Cells Mobilization, colLection and Engraftment in Newly

    Recruiting
    • Multiple Myeloma
    • +3 more
    • Rome, Italy
      Fondazione Policlinico Universitario A.Gemelli IRCCS
    Apr 28, 2023

    Multiple Myeloma, New Diagnosis Tumor Trial in Hangzhou (BCMA CAR-T cells)

    Recruiting
    • Multiple Myeloma
    • New Diagnosis Tumor
    • BCMA CAR-T cells
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Jan 31, 2023

    Multiple Myeloma Trial in Cleveland (Palliative Care, FACT-MM questionnaire, HADS questionnaire)

    Recruiting
    • Multiple Myeloma
    • Palliative Care
    • +2 more
    • Cleveland, Ohio
      Cleveland Clinic, Case Comprehensive Cancer Center
    Jan 17, 2023

    MRD-tailored Therapy in Newly Diagnosed Multiple Myeloma With

    Not yet recruiting
    • Multiple Myeloma
    • Minimal Residual Disease
      • (no location specified)
      Nov 1, 2023

      Multiple Myeloma Prognostic Indices

      Recruiting
      • Multiple Myeloma
      • Hematologic Diseases
      • blood viscosity , albumin / fibrinogen ratio and red cell distribution
      • Assiut, Egypt
        Assiut University hospital
      Oct 17, 2023

      Daratumumab in Combination With Bortezomib, Thalidomide, and

      Not yet recruiting
      • Newly Diagnosed Multiple Myeloma
      • Daratumumab in Combination with Bortezomib, Thalidomide, and Dexamethasone Regimens
      • (no location specified)
      Sep 27, 2022

      Newly Diagnosed Multiple Myeloma Trial in New York (Daratumumab, Bortezomib, Lenalidomide)

      Recruiting
      • Newly Diagnosed Multiple Myeloma
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Dec 29, 2022

      Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the

      Not yet recruiting
      • Multiple Myeloma
      • +2 more
      • 18F-fluciclovine injection
      • 18F-FDG PET/CT
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Oct 31, 2023

      Multiple Myeloma Trial in China (Selinexor, Bortezomib, Lenalidomide)

      Recruiting
      • Multiple Myeloma
      • Changzhou, Jiangsu, China
      • +5 more
      Jun 11, 2023

      Plasma Cell Myeloma Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

      Active, not recruiting
      • Plasma Cell Myeloma
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Jan 10, 2023

      Multiple Myeloma Trial (Teclistamab, Daratumumab, Lenalidomide)

      Not yet recruiting
      • Multiple Myeloma
      • (no location specified)
      Oct 6, 2022

      Multiple Myeloma Trial in United States (Daratumumab, Lenalidomide, Bortezomib)

      Recruiting
      • Multiple Myeloma
      • Ann Arbor, Michigan
      • +3 more
      Jan 19, 2023

      Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

      Recruiting
      • Multiple Myeloma
      • +2 more
      • Wuhan, Hubei, China
        Institute of Hematology, Union Hospital, Tongji Medical College,
      Nov 18, 2023

      Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)

      Not yet recruiting
      • Multiple Myeloma
      • +7 more
      • Belantamab Mafodotin-Blmf
      • +3 more
      • (no location specified)
      Oct 11, 2022

      Multiple Myeloma Trial in United States (daratumumab, carfilzomib, lenalidomide)

      Active, not recruiting
      • Multiple Myeloma
      • Basking Ridge, New Jersey
      • +6 more
      Dec 28, 2022

      Multiple Myeloma Trial in Guangzhou (Selinexor, Bortezomib, Lenalidomide)

      Recruiting
      • Multiple Myeloma
      • Guangzhou, Guangdong, China
      • +3 more
      Aug 16, 2022

      Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, Selinexor-VRD)

      Recruiting
      • Multiple Myeloma
      • Tianjin, China
        Institute of Hematology and Blood Diseases Hospital Chinese Acad
      May 12, 2023

      Multiple Myeloma Trial in Denmark, Ireland (Isatuximab, Bortezomib, Lenalidomide)

      Recruiting
      • Multiple Myeloma
      • Aarhus, Denmark
      • +5 more
      Jul 29, 2022

      Multiple Myeloma Trial in Shanghai (GC012F injection)

      Not yet recruiting
      • Multiple Myeloma
      • GC012F injection
      • Shanghai, Shanghai, China
        Shanghai Changzheng Hospital
      May 1, 2023

      Multiple Myeloma, Cancer Trial in Chapel Hill, Durham, Columbus (Isatuximab, Lenalidomide, Dexamethasone)

      Recruiting
      • Multiple Myeloma
      • Cancer
      • Chapel Hill, North Carolina
      • +2 more
      Jun 30, 2022

      Multiple Myeloma Trial in Torino (Carfilzomib, Cyclophosphamide, Dexamethasone)

      Active, not recruiting
      • Multiple Myeloma
      • Torino, Italy
        Fondazione EMN Italy Onlus
      Mar 24, 2022

      Multiple Myeloma Trial in Torino (Carfilzomib, Cyclophosphamide, Dexamethasone)

      Active, not recruiting
      • Multiple Myeloma
      • Torino, Italy
        Fondazione EMN Italy Onlus
      Mar 24, 2022

      Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)

      Recruiting
      • Multiple Myeloma
      • Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
      • +7 more
      Jan 9, 2023